UNSPSC 51144701: Flucetorex

This classification denotes an anorexiant, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 0JJT8MQ49S. European Medicines Agency schedules Flucetorex in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07669MIG. Flucetorex generally arises in the molecular formula C20H21F3N2O3.

UNSPSC 51144701 Flucetorex, a Commodity code, does not map cleanly to the state and local procurement activity recently tagged under it. The three most recent opportunities solicited under this code involve naloxone acquisition, therapeutic pharmacy direct-to-manufacturer programs, and generic multi-source pharmaceutical distribution through cooperative purchasing — none of which involve flucetorex specifically or pharmaceutical compounds matching the code's nominal scope. The mismatch suggests either classification drift in the issuing systems or that flucetorex occupies a narrow, infrequently procured niche within state and local health and human services procurement.

The issuing bodies reflect typical state and local health procurement: Seminole County, Florida (county government), Texas Health and Human Services Commission (state agency), and the Minnesota Multistate Cooperative Purchasing Alliance (state cooperative purchasing vehicle spanning multiple states including Oregon). The most concrete recent opportunity is Seminole County's IFB 60459723LAS, posted June 30, 2026, with response due July 26, 2023 — soliciting 1,900 units of naloxone and 800 safe drug deactivation systems annually through quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida, with a two-year initial term plus one-year renewal option on a fixed-fee basis. Geographic activity centers in Florida and Texas, with cooperative purchasing vehicles extending across multiple states. The absence of recent flucetorex-specific solicitations suggests this code warrants monitoring rather than active pursuit unless firm demand signals emerge in state health department pharmaceutical procurement channels.